Aerie Pharmaceuticals, Inc. Names Vicente Anido, Jr. as Chairman of the Board, and David Epstein as Chairman of Aerie’s Scientific Advisory Board

Aerie Pharmaceuticals, Inc. announced today that Vicente Anido, Jr., Ph.D., was named Chairman of Aerie’s Board of Directors. Dr. Anido is a well-respected ophthalmology industry veteran and leader, who most recently served as President and Chief Executive Officer of ISTA Pharmaceuticals prior to its acquisition by Bausch + Lomb. Aerie also announced that David Epstein, M.D., Chairman, Department of Ophthalmology, Duke University School of Medicine, and Aerie Co-Founder, has been named as Chairman of the Company’s Scientific Advisory Board.

Back to news